Level Bio AB (LEVBIO)

Currency in SEK
0.2800
0.0000(0.00%)
Delayed Data·
LEVBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.24000.2800
52 wk Range
0.22200.5500
Key Statistics
Prev. Close
0.321
Open
0.24
Day's Range
0.24-0.28
52 wk Range
0.222-0.55
Volume
-
Average Volume (3m)
34.41K
1-Year Change
-14.1104%
Book Value / Share
0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LEVBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Level Bio AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Level Bio AB Earnings Call Summary for Q3/2025

  • Level Bio reported Q3 revenue of 6.7M SEK (+5% YoY), with 9-month revenue up 30% to 23M SEK, surpassing 2024's full-year sales
  • Gross margin improved 5 percentage points to 57%, with positive cash flow achieved despite a slight net loss of 160,000 SEK
  • Company focuses on next-gen sequencing and single-cell analysis for future growth, eyeing expansion in Middle East and South America
  • No specific financial guidance provided, but management expressed confidence in maintaining growth trajectory
  • Stock declined 5.05% to 0.321 SEK; InvestingPro analysis suggests undervaluation at current levels
Last Updated: 2025-10-23, 08:42 a/m
Read Full Transcript

Earnings

Latest Release
Apr 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
9.02M / --
EPS Revisions
Last 90 days

LEVBIO Income Statement

Compare LEVBIO to Peers and Sector

Metrics to compare
LEVBIO
Peers
Sector
Relationship
P/E Ratio
−6.7x21.7x−0.3x
PEG Ratio
−0.11−1.030.00
Price/Book
40.9x3.2x2.6x
Price / LTM Sales
0.6x6.5x3.1x
Upside (Analyst Target)
-19.1%49.0%
Fair Value Upside
Unlock−15.0%6.3%Unlock

Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.46K0.00%409.64
Other Institutional Investors
34.75M50.80%9.73M
Public Companies & Retail Investors
33.65M49.20%9.42M
Total
68.4M100.00%19.15M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Labkompaniet AB29.06%19,873,6195,565
Nordnet Pensionsförsäkring AB8.93%6,110,6621,711

FAQ

What Is the Level Bio AB (LEVBIO) Stock Price Today?

The Level Bio AB stock price today is 0.2800 SEK.

What Stock Exchange Does Level Bio AB Trade On?

Level Bio AB is listed and trades on the Nordic Growth Market.

What Is the Stock Symbol for Level Bio AB?

The stock symbol for Level Bio AB is "LEVBIO."

What Is the Level Bio AB Market Cap?

As of today, Level Bio AB market cap is 19.1500M SEK.

What Is Level Bio AB's Earnings Per Share (TTM)?

The Level Bio AB EPS (TTM) is -0.0420.

From a Technical Analysis Perspective, Is LEVBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Level Bio AB Stock Split?

Level Bio AB has split 1 times.

How Many Employees Does Level Bio AB Have?

Level Bio AB has 10 employees.

What is the current trading status of Level Bio AB (LEVBIO)?

As of Aug 18, 2026, Level Bio AB (LEVBIO) is trading at a price of 0.2800 SEK, with a previous close of 0.3210 SEK. The stock has fluctuated within a day range of 0.2400 SEK to 0.2800 SEK, while its 52-week range spans from 0.2220 SEK to 0.5500 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.